abs64.txt	objectives		the	objectives	of	this	study	were	to	define	dietary	supplement	(ds)use	by	cancer	patients	and	to	investigate	factors	associated	with	ds	use	duringcancer	treatment	methods		a	cross-sectional	survey	of	adults	diagnosed	with	breast		colorectal	lung		or	prostate	cancer	in	2010-2012	at	the	university	of	north	carolinacomprehensive	cancer	center	was	conducted		questionnaires	were	sent	to	1794patients		phone	calls	were	made	to	nonrespondents		the	authors	described	type	ofds	use	before		during		and	after	initial	cancer	treatment		source	of	advice	on	dsuse		and	used	logistic	regression	to	investigate	the	association	of	ds	use	duringor	after	cancer	treatment	with	clinical/sociodemographic	characteristics	andsource	of	advice	results		six	hundred	and	three	(34%)	patients	completed	the	questionnaires	nonvitamin	nonmineral	ds	use	during	initial	cancer	treatments	was	common		anycancer	treatment	(49%)		chemotherapy	(52%)		and	radiation	therapy	(51%)		amongpatients	seeking	advice	on	ds	use		75%	reported	professional	sources		44%reported	media	sources		and	47%	reported	lay	sources		ds	use	during	cancertreatment	was	strongly	predicted	by	prior	ds	use		followed	by	prior	complementarytherapies'	use		receiving	ds	advice	from	a	cancer	care	provider		being	female	and	higher	education	level	conclusion		ds	use	is	common	and	persists	during	cancer	treatment		among	ds	usersduring	treatment		18%	used	an	herbal	supplement		which	are	likely	to	carrygreater	risk	of	interaction	with	chemotherapy	agents	compared	with	vitamin	mineral		and	other	supplements		although	many	respondents	sought	ds	advice	fromprofessional	sources		the	use	of	nonprofessional	sources	remains	high	
